Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-05

Clinical Trial Update: A Food-effect Study of the Pediatric Dispersible Tablet Formulations of TRIUMEQ® and DOVATO® in Healthy Adult Participants [Phase 1]

View source ↗

Summary

Phase 1 study assessing the food-effect of pediatric dispersible tablet formulations of TRIUMEQ and DOVATO in healthy adults; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dovato (dolutegravir/lamivudine)
  • Triumeq (dolutegravir/abacavir/lamivudine)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2023-06-05